Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Harlan Expands Switzerland Site | Contract Pharma

What are you searching for?

Sign in
Breaking News

Harlan Expands Switzerland Site

Invests $4.5 million in Itingen

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Harlan Laboratories Contract Research Services (CRS) is investing $4.5 million in its Itingen, Switzerland site. The investment will expand its range of testing and research services at the site and will include enhancements to the inhalation facility, upgrading the barrier protected area for chronic and subchronic studies and an entire floor dedicated to reproductive and rodent toxicology. The company will also build new lab areas for clinical diagnostics, biochemical analysis and fetal pathology.
 
The investment follows Harlan’s consolidation of its Füllinsdorf operations into the Itingen site.  Harlan has also launched a recruitment effort to expand its Histology expertise, along with new processing equipment.   
 
“This is an exciting development which we believe will offer many benefits to our customers,” said Hans Thunem, chief executive officer of Harlan Laboratories. “We indicated last year that our commitment to our operations in Switzerland was strong but being tested by lack of profitability.  With the results delivered by our employees over the last 12 months, it is rewarding to now be able to make new investments in our Swiss operations.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics